Anna Sher

机构：Pfizer (United States), TE Laboratories (Ireland), Ship Modelling & Simulation Centre · ORCID：0000-0001-7159-0173

发表论文 39 篇 · 总被引 724 次 · h-index 11

代表论文

• Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk (2011 · Cardiovascular Research · 被引 337)
• A Quantitative Systems Pharmacology Perspective on the Importance of Parameter Identifiability (2022 · Bulletin of Mathematical Biology · 被引 48)
• A Prototype QSP Model of the Immune Response to SARS‐CoV‐2 for Community Development (2020 · CPT Pharmacometrics & Systems Pharmacology · 被引 33)
• Quantitative analysis of variability in an integrated model of human ventricular electrophysiology and β-adrenergic signaling (2020 · Journal of Molecular and Cellular Cardiology · 被引 23)
• AMPK activation is sufficient to increase skeletal muscle glucose uptake and glycogen synthesis but is not required for contraction-mediated increases in glucose metabolism (2022 · Heliyon · 被引 17)
• A local sensitivity analysis method for developing biological models with identifiable parameters: Application to cardiac ionic channel modelling (2011 · Future Generation Computer Systems · 被引 17)